A. Guernet

发表

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

K. Politi, W. Lockwood, Paul D. Smith, 2020, Cancer Research.

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

K. Politi, W. Lockwood, Paul D. Smith, 2020, Cancer Research.

CRISPR/Cas9 editing of the genome for cancer modeling.

L. Grumolato, A. Guernet, 2017, Methods.

CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations.

Sathish Kumar Mungamuri, R. Sachidanandam, S. K. Mungamuri, 2016, Molecular cell.

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells

A. Bardelli, B. Cho, C. Coulouarn, 2023, bioRxiv.

CRISPR/Cas9 editing of the genome for cancer modeling.

L. Grumolato, A. Guernet, 2017, Methods.